06 August 2018
Visiongain’ has launched a new pharma report Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market : Antifibrotics, Tyrosine Kinase Inhibitors, Anti-inflammatory Drugs, Immunosuppressants, Other MoA, Innovator Drugs, Off-label Drugs
This report is intended to provide an in-depth analysis of the latest trends of the Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market and its growth and development in the next decade. The changing demographics of the world population, emerging economies, consumer spending behaviour, per capita income, macroeconomic factors, rising GDPs, and the reformation in laws and regulations are trend setting factors, which will affect the market.
This report examines in detail the market forecast by geography, by mechanism of action, as well as by innovator & off-label drugs during 2017-2027, providing the reader with a thorough overview of the market to identify key growth areas and business opportunities.
The lead analyst of the report commented “The global anti-idiopathic pulmonary fibrosis drugs market is driven by the rising prevalence and incidence of IPF patients, expected launch of novel therapies, special regulatory (Orphan and Fast-track) designations for pipeline molecules, increased understanding of disease pathogenesis, and limited number of current players.
However, the growth of this market might be slowed down by various challenges during the forecast period with use of off-label drugs, availability of non-pharmacological therapies, and lack of proper diagnosis techniques as well as the absence of highly efficacious & safe drugs.”
Leading companies featured in the report include Actelion, Afferent Pharmaceuticals, Asahi Kasei Pharma, Bellerophon Therapeutics, Biogen, Boehringer Ingelheim, FibroGen, Galapagos, Galecto Biotech, Genentech, Global Blood Therapeutics, GSK, Kadmon Pharmaceuticals, LTT, Bio-Pharma, MediciNova, Merck, Moerae, Pacific Therapeutics, Promedior, ProMetic Life Sciences, Roche, Sanofi, Teva, Zai Lab
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
18 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.
12 January 2021
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
11 January 2021
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.